홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

2-(4-(azidomethyl)-1H-imidazol-1-yl)-5-bromopyridine → (1-(5-bromopyridin-2-yl)-1H-imidazol-4-yl)methanamine

HRID 643008
노트
인쇄 미리보기

반응식

HRID 643008 반응식
[N:1]([CH2:4][C:5]1[N:6]=[CH:7][N:8]([C:10]2[CH:15]=[CH:14][C:13]([Br:16])=[CH:12][N:11]=2)[CH:9]=1)=[N+]=[N-]>CCO.CC(O)=O.[Fe]>[Br:16][C:13]1[CH:14]=[CH:15][C:10]([N:8]2[CH:9]=[C:5]([CH2:4][NH2:1])[N:6]=[CH:7]2)=[N:11][CH:12]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

5

반응물 1

HCID 866140062-(4-(azidomethyl)-1H-imidazol-1-yl)-5-bromopyridine

생성물 1

HCID 68502878(1-(5-bromopyridin-2-yl)-1H-imidazol-4-yl)methanamine수율 55.8%

시약·촉매·용매 3

HCID 23925Iron촉매HCID 176Acetic Acid용매HCID 702Ethanol용매

실험 절차

A mixture of 2-(4-(azidomethyl)-1H-imidazol-1-yl)-5-bromopyridine (500 mg, 1.79 mmol) and iron powder (767 mg, 13.7 mmol) in EtOH (8 mL) and HOAc (6 mL) was heated at reflux for 2 h. It was filtered through celite. The filtrate was concentrated in vacuo. The residue was partitioned between 5% NaHCO3 and EtOAc. The biphasic solution was filtered. The EtOAc phase was separated, dried over Na2SO4, and concentrated in vacuo to give (1-(5-bromopyridin-2-yl)-1H-imidazol-4-yl)methanamine (253 mg).

후처리

  1. temperaturewas heated
  2. temperatureat reflux for 2 h
  3. filtrationIt was filtered through celite
  4. concentrationThe filtrate was concentrated in vacuo
  5. customThe residue was partitioned between 5% NaHCO3 and EtOAc
  6. filtrationThe biphasic solution was filtered
  7. customThe EtOAc phase was separated
  8. dry with materialdried over Na2SO4
  9. concentrationconcentrated in vacuo

출처 및 근거

ORD 기록
ord-55b44155e890468e94800070c96ed5ae
출처 데이터셋
uspto-grants-2010_04
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07696352B2

반응 노트

불러오는 중…

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트